Dentsply Sirona

XRAY

Market cap $2.55B

CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, November 6, 2025, at 8:30 am ET to review its financial results for the third quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.

CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer (CCO), effective October 6, 2025. The appointment is designed to sharpen the Company's focus on the customer by aligning its Global Business Units and Commercial Organizations more closely - streamlining how Dentsply Sirona works and delivers.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

LOS ANGELES--(BUSINESS WIRE)-- #ArtificialIntelligence--Dentsply Sirona adds Pearl's Second Opinion dental AI capabilities to its cloud-based DS Core imaging software.

XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Baird 2025 Global Healthcare Conference September 9, 2025 1:25 PM EDT Company Participants Matthew Garth - Executive VP & CFO Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Presentation Jeffrey Johnson Senior Research Analyst All right.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Company Participants Daniel Scavilla - President, CEO & Director Matthew Garth - Executive VP & CFO Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good afternoon, everyone. My name is Erin Wright, the health care services analyst at Morgan Stanley.

Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

CHARLOTTE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.